Current Neuro-Oncology
Volume
23 Number 3
15 February 2021
Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 3, 15 February
*
Gao
XY, Zang J, Zheng MH, Zhang YF, Yue KY, Cao XL, Cao Y, Li XX, Han
H, Jiang XF, Liang L.
Temozolomide
Treatment Induces HMGB1 to Promote the Formation of Glioma Stem
Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma.
Front
Cell Dev Biol. 2021 Feb 1, 2021;9:620883∟.
doi: 10.3389/fcell.2021.620883∟.
PMID: 33614649∟.
Laboratory investigation. ˍ
Padovan
M, Caccese M, Zagonel V, Lombardi G.
Prolonged
benefit to pembrolizumab in anaplastic oligodendroglioma patient
with mismatch repair deficiency: a case report.
Anticancer
Drugs. 2021 Feb 1, 2021;32(2):218-221∟.
doi: 10.1097/CAD.0000000000001011∟.
PMID: 33395066∟.
Case report˰ ˍ
Neville
IS, Dos Santos AG, Almeida CC, Abaurre LB, Wayhs SY, Feher O,
Teixeira MJ, Lepski G.
Reoperation
for recurrent glioblastomas: What to expect?
Surg
Neurol Int. 2021 Feb 3, 2021;12:42∟.
doi: 10.25259/SNI_538_2020∟.
PMID: 33598358∟.
Observational study. ˍ
Noch
EK, Sait SF, Farooq S, Trippett TM, Miller AM.
A
case series of extraneural metastatic glioblastoma at Memorial
Sloan Kettering Cancer Center.
Neurooncol
Pract. 2021 Feb 3, 2021;8(3):325-336∟.
doi: 10.1093/nop/npaa083∟.
PMID: 34055380∟.
Case report. ˍ
Papusha
L, Zaytseva M, Druy A, Valiakhmetova A, Yasko L, Salnikova E,
Shekhtman A, Karachunsky A, Maschan A, Hwang EI, Novichkova G,
Packer RJ.
The
experience of successful treatment of ETV6-NTRK3-positive
infant glioblastoma with entrectinib.
Neurooncol
Adv. 2021 Feb 3, 2021;3(1):vdab022∟.
doi: 10.1093/noajnl/vdab022∟.
PMID: 33738452∟.
Case report. ˍ
Ge
J, Li C, Xue F, Qi S, Gao Z, Yu C, Zhang J.
Apatinib
Plus Temozolomide: An Effective Salvage Treatment for Recurrent
Glioblastoma.
Front
Oncol. 2021 Feb 4, 2021;10:601175∟.
doi: 10.3389/fonc.2020.601175∟.
PMID: 33634023∟.
Observational study. ˍ
*
Qin
X, Liu R, Akter F, Qin L, Xie Q, Li Y, Qiao H, Zhao W, Jian Z, Liu
R, Wu S.
Peri-tumoral
brain edema associated with glioblastoma correlates with tumor
recurrence.
J
Cancer. 2021 Feb 5, 2001;12(7):2073-2082∟.
doi: 10.7150/jca.53198∟.
PMID: 33754006∟.
Observational
study.
ˍ
Eid
AM, Heabah NAE.
Medulloblastoma:
clinicopathological parameters, risk
stratification,
and survival analysis of immunohistochemically validated
molecular
subgroups.
J
Egypt Natl Canc Inst. 2021 Feb 8, 2021;33(1):6∟.
doi: 10.1186/s43046-021-00060-w∟.
PMID: 33555447∟.
Laboratory investigation.
ˍ
Soliman
S, Ghaly M.
Ischemic
Stroke After Tumor Resection in a Patient With Glioblastoma
Multiforme.
Cureus.
2021 Feb 8, 2021;13(2):e13232∟.
doi: 10.7759/cureus.13232∟.
PMID: 33728181∟.
Case report. ˍ
Xu
Y, He X, Li Y, Pang P, Shu Z, Gong X.
The
Nomogram of MRI-based Radiomics with Complementary Visual Features
by Machine Learning Improves Stratification of Glioblastoma
Patients: A Multicenter Study.
J
Magn Reson Imaging. 2021 Feb 8∟.
doi: 10.1002/jmri.27536∟.
PMID: 33559302∟.
Observational
study. ˍ
Lopez-Nunez
O, Alaggio R, John I, Ciolfi A, Pedace L, Mastronuzzi A, Gianno F,
Giangaspero F, Rossi S, Donofrio V, Cinalli G, Surrey LF,
Tartaglia M, Locatelli F, Miele E.
Melanotic
Neuroectodermal Tumor of Infancy (MNTI) and
Pineal
Anlage Tumor (PAT) Harbor A Medulloblastoma Signature by DNA
Methylation
Profiling.
Cancers
(Basel). 2021 Feb 9, 2021;13(4):706∟.
doi: 10.3390/cancers13040706∟.
PMID: 33572349∟.
Laboratory investigation.
ˍ
Zhao
C, Li L, Guo X, Song D, Wang M, Zhai Y, Yang F, Xue Y, Wei
X.
Preoperative
Predictors of Early Mortality Risk in Isocitrate
Dehydrogenase-Wild-Type Glioblastoma Patients Treated with
Standard Therapy.
Cancer
Manag Res. 2021 Feb 9, 2021;13:1159-1168∟.
doi: 10.2147/CMAR.S290053∟.
PMID: 33603461∟.
Observational study. ˍ
Shibahara
I, Miyasaka K, Sekiguchi A, Ishiyama H, Inukai M, Yasui Y,
Watanabe T, Sato S, Hide T, Kumabe T.
Long-term
follow-up after BCNU wafer implantation in patients with newly
diagnosed glioblastoma.
J
Clin Neurosci. 2021 Feb 10, 2021;86:202-210∟.
doi: 10.1016/j.jocn.2021.01.037∟.
PMID: 33775329∟.
Observational
study. ˍ
Courtney
M, Johnston C, Nasoodi A.
Meningioma
uptake of 68Gallium-PSMA-11
as a pitfall on positron emission tomography/computer
tomography.
Acta
Radiol Open. 2021 Feb 11, 2021;10(2):2058460120981001∟.
doi: 10.1177/2058460120981001∟.
PMID: 33628459∟.
Case Report. ˍ
Kluckova
K, Kozak J, Szaboova K, Suchankova M, Svajdler M, Blazickova S,
Makohusova M, Steno J, Matejcik V, Bucova M.
Low
serum vitamin D levels are associated with a low percentage of
TREM-2+ monocytes in low-grade gliomas and poorer overall survival
in patients with high-grade gliomas.
Bratisl
Lek Listy. 2021 Feb 12, 2021;122(3):172-178∟.
doi: 10.4149/BLL_2021_027∟.
PMID: 33618524∟.
Observational
study.
ˍ
Schönthal
AH, Peereboom DM, Wagle N, Lai R, Mathew AJ, Hurth KM, Simmon VF,
Howard SP, Taylor LP, Chow F, da Fonseca CO, Chen TC.
Phase
I trial of intranasal NEO100, highly purified perillyl alcohol, in
adult patients with recurrent glioblastoma.
Neurooncol
Adv. 2021 Feb 12, 2021;3(1):vdab005∟.
doi: 10.1093/noajnl/vdab005∟.
PMID: 33604574∟.
Interventional study. ˍ
Bray
DP, Quillin JW, Press RH, Yang Y, Chen Z, Eaton BR, Olson
JJ.
Adjuvant
Radiotherapy Versus Watchful Waiting for World Health Organization
Grade II Atypical Meningioma: A Single-Institution
Experience.
Neurosurgery.
2021 Feb 13, 2021;88(5):E435-E442∟.
doi: 10.1093/neuros/nyaa580∟.
PMID: 33582821∟.
Observational study. ˍ
Fisher
MJ, Jones DTW, Li Y, Guo X, Sonawane PS, Waanders AJ, Phillips JJ,
Weiss WA, Resnick AC, Gosline S, Banerjee J, Guinney J, Gnekow A,
Kandels D, Foreman NK, Korshunov A, Ryzhova M, Massimi L,
Gururangan S, Kieran MW, Wang Z, Fouladi M, Sato M, Øra I,
Holm S, Markham SJ, Beck P, Jäger N, Wittmann A, Sommerkamp
AC, Sahm F, Pfister SM, Gutmann DH.
Integrated
molecular and clinical analysis of low-grade gliomas in children
with neurofibromatosis type 1 (NF1).
Acta
Neuropathol. 2021 Feb 14, 2021;141(4):605-617∟.
doi: 10.1007/s00401-021-02276-5∟.
PMID: 33585982∟.
Laboratory investigation. ˍ
Chai
R, Li G, Liu Y, Zhang K, Zhao Z, Wu F, Chang Y, Pang B, Li J, Li
Y, Jiang T, Wang Y.
Predictive
value of MGMT promoter methylation on the survival of TMZ treated
IDH-mutant
glioblastoma.
Cancer
Biol Med. 2021 Feb 15, 2021;18(1):272-282∟.
doi: 10.20892/j.issn.2095-3941.2020.0179∟.
PMID: 33628600∟.
Observational study. ˍ
Juarez
TM, Piccioni D, Rose L, Nguyen A, Brown B, Kesari S.
Phase
I dose-escalation, safety, and CNS pharmacokinetic study of
dexanabinol in patients with brain cancer.
Neurooncol
Adv. 2021 Feb 15, 2021;3(1):vdab006∟.
doi: 10.1093/noajnl/vdab006∟.
PMID: 33615223∟.
Interventional study. ˍ
Lao
Y, Yu V, Pham A, Wang T, Cui J, Gallogly A, Chang E, Fan Z,
Kaprealian T, Yang W, Sheng K.
Quantitative
Characterization of Tumor Proximity to Stem Cell Niches:
Implications on Recurrence and Survival in GBM Patients.
Int
J Radiat Oncol Biol Phys. 2021 Feb 15, 2021;110(4):1180-1188∟.
doi: 10.1016/j.ijrobp.2021.02.020∟.
PMID: 33600888∟.
Observational study. ˍ
Marinari
E, Dutoit V, Nikolaev S, Vargas MI, Schaller K, Lobrinus JA,
Dietrich PY, Tsantoulis P, Migliorini D.
Clonal
Evolution of a High-Grade Pediatric Glioma With Distant Metastatic
Spread.
Neurol
Genet. 2021 Feb 15, 2021;7(2):e561∟.
doi: 10.1212/NXG.0000000000000561∟.
PMID: 33898738∟.
Case report. ˍ
Nuechterlein
N, Li B, Feroze A, Holland EC, Shapiro L, Haynor D, Fink J, Cimino
PJ.
Radiogenomic
modeling predicts survival-associated prognostic groups in
glioblastoma.
Neurooncol
Adv. 2021 Feb 15, 2021;3(1):vdab004∟.
doi: 10.1093/noajnl/vdab004∟.
PMID: 33615222∟.
Observational study. ˍ
Wang
Y, Feng LL, Ji PG, Liu JH, Guo SC, Zhai YL, Sankey EW, Wang Y, Xue
YR, Wang N, Lou M, Xu M, Chao M, Gao GD, Qu Y, Gong L, Wang
L.
Clinical
Features and Molecular Markers on Diffuse Midline Gliomas With
H3K27M Mutations: A 43 Cases Retrospective Cohort Study.
Front
Oncol. 2021 Feb 15, 2021;10:602553∟.
doi: 10.3389/fonc.2020.602553∟.
PMID: 33659209∟.
Observational study. ˍ